| Literature DB >> 33118742 |
Dustin Greve1, Joana Funke1,2, Tiam Khairi1,2, Matteo Montagner2, Christoph Starck2, Volkmar Falk1,2,3,4, Michel Pompeu B O Sá5, Stephan D Kurz1,2.
Abstract
INTRODUCTION: Cocaine use is known to be associated with an increased risk for vascular diseases. It is likely to trigger or increase the risk for an aortic dissection. We conducted an analysis of 45 cases of cocaine-related aortic dissection to further characterize the clinical features and outcomes of this patient cohort.Entities:
Keywords: Aneurysm; Dissection. Cocaine-Related Disorders. Aortic Aneurysm; Thoracic. Vascular Surgical Procedures. Treatment Outcome
Year: 2020 PMID: 33118742 PMCID: PMC7598981 DOI: 10.21470/1678-9741-2020-0333
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Characteristics of the study population. Shares are given as "N (%)", measurements are given as "mean (+/- standard deviation)".
| N | 45 |
| Males | 40 (88.9) |
| Age, years | 41.3 (8.67) |
|
| |
| Chest pain | 23/37 (62.2) |
| Pain radiating to back | 6/23 (26) |
| Back pain | 6/37 (16.2) |
| Abdominal pain | 9/37 (24.3) |
| Headache | 1/37 (2.7) |
| Dyspnea | 4/37 (10.8) |
| Nausea | 6/37 (16.2) |
| Paresthesia of a limb | 4/37 (10.8) |
| Syncope | 2/37 (5.4) |
| Found dead | 5/44 (11.1) |
|
| |
| Known history of hypertension | 29/39 (74.4) |
| Hypertension on admission | 19/33 (57.6) |
| Systolic blood pressure on admission, mmHg | 154.13 (45.82) |
| Diastolic blood pressure on admission, mmHg | 91.97 (35.86) |
|
| |
| History of nicotine use | 21/25 (84) |
| Cocaine use for over 1 year | 18/25 (72) |
| Hours from cocaine use to symptom | 11 (22.13) |
|
| |
|
| |
| Type A | 33/44 (75) |
| Type B | 11/44 (25) |
|
| |
| Surgical | 31/39 (79.5) |
| Medical | 8/39 (20.5) |
|
| |
| Days until discharge | 13 (10.67) |
|
| |
| In-hospital mortality | 9/42 (21.4) |
| Pre-hospital mortality | 5/42 (11.9) |
| Days until death | 9.25 (13.59) |
|
| |
Comparison of our study cohort with other published case series of aortic dissections and cocaine use.
| Characteristics | Daniel et al.[ | Dean et al.[ | Hsue et al.[ | Singh et al.[ | Yammine et al.[ | Our study |
|---|---|---|---|---|---|---|
| N | 16 | 63 | 14 | 13 | 14 | 45 |
| Age (years) | 47±6.8 | 47±11 | 41±8,8 | 38±9 | 52.6±7.4 | 41±8,6 |
| Gender (male) | 12 (75%) | 55 (87%) | 8 (57%) | 9 (69%) | 10 (71.4%) | 40 (88.9%) |
| History of nicotine abuse | 16 (100%) | 39 (61%) | 14 (100%) | 13 (100%) | 11 (78.6%) | 21/25 (84%) |
| History of hypertension | 11 (69%) | 52 (82%) | 11 (79%) | 9 (69%) | 14 (100%) | 29/39 (74.4%) |
| Time from cocaine use to symptoms (mean) | 12,8 h (4-24 h) | NR | 12 h (0-24 h) | 0-48 h | NR | 11 h (0-72 h) |
| Chest pain | NR | 51 (81%) | NR | NR | NR | 23/37 (62.2%) |
| Stanford type A | 44% | 33 (52.4%) | 6 (43%) | 4 (31%) | 0 (0%) | 33/44 (75%) |
| Stanford type B | 57% | 30 (47.6%) | 8 (57%) | 9 (69%) | 14 (100%) | 11/44 (25%) |
| Surgical treatment | 50% | 31 (49%) | 9 (64%) | - | 14 (100%) | 31/39 (79.5%) |
| Mortality | 31% | 8% | - | 69% | 7% | 9/42 (21.4%) |
NR=not reported
Endovascular treatment.
| Abbreviations, acronyms & symbols | |
|---|---|
|
|
|
|
|
|
| Authors' roles & responsibilities | |
|---|---|
| DG | Substantial contributions to the conception or design of the work; analysis and interpretation of data for the work; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| JF | Analysis and interpretation of data for the work; final approval of the version to be published |
| TK | Analysis and interpretation of data for the work; final approval of the version to be published |
| MM | Analysis and interpretation of data for the work; final approval of the version to be published |
| CS | Analysis and interpretation of data for the work; final approval of the version to be published |
| VF | Analysis and interpretation of data for the work; final approval of the version to be published |
| MPBOS | Analysis and interpretation of data for the work; final approval of the version to be published |
| SDK | Substantial contributions to the conception or design of the work; analysis and interpretation of data for the work; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |